Accolade

In January, Transcarent announced it was acquiring Accolade and taking it private.

According to a filing with the Securities and Exchange Commission, the company still plans to hire "to support its service capacity needs and growth expectations."

What comes after the pandemic? Accolade CMO Dr. Shantanu Nundy and Pfizer's senior director for clinical informatics, Saira Haque, discuss how COVID-19 has changed partnerships between players in the healthcare industry and what they can learn.

The move is expected to help Accolade further its foothold in primary care. 

Also: Providence supporting COVID-19 patients at home with Xealth and Twistle; Lief Therapeutics incorporates DrChrono's Open API.

The timing and pricing of the Seattle company's IPO are yet to be determined.

Last week on-demand healthcare concierge for provider employers Accolade received $50 million in funding led by Andreessen Horowitz, Carrick Capital Partners, Madrona Venture Group, and McKesson Ventures, with participation from Cross Creek Advisors and Madera Technologies.